Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ganten

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugsTom M Ganten, Ronald Koschny, Jaromir Sykora, et al.
Journal of Neuro-Oncology|September 22, 2009
Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosisRonald Koschny, Heidrun Holland, Jaromir Sykora, et al.
European Journal of Radiology|December 11, 2012
Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histologyT Bäuerle, L Seyler, M Münter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosisRonald Koschny, Heidrun Holland, Jaromir Sykora, et al.
Langenbeck'S Archives of Surgery|May 3, 2011
The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantationArianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, et al.
Clinical Transplantation|February 15, 2013
Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER)Hans J Schlitt, Sven Jonas, Tom M Ganten, et al.
BMC Cancer|November 12, 2013
Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinomaRonald Koschny, Sylvia Brost, Ulf Hinz, et al.
Pathology, Research and Practice|December 8, 2014
WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningiomaRonald Koschny, Wolfgang Krupp, Li-Xin Xu, et al.
Cell Death and Differentiation|April 24, 2004
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugsT M Ganten, T L Haas, J Sykora, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2014
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complexRonald Koschny, Christina Boehm, Martin R Sprick, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugsTom M Ganten, Ronald Koschny, Jaromir Sykora, et al.
Journal of Neuro-Oncology|September 22, 2009
Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosisRonald Koschny, Heidrun Holland, Jaromir Sykora, et al.
European Journal of Radiology|December 11, 2012
Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histologyT Bäuerle, L Seyler, M Münter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosisRonald Koschny, Heidrun Holland, Jaromir Sykora, et al.
Langenbeck'S Archives of Surgery|May 3, 2011
The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantationArianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, et al.
Clinical Transplantation|February 15, 2013
Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER)Hans J Schlitt, Sven Jonas, Tom M Ganten, et al.
BMC Cancer|November 12, 2013
Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinomaRonald Koschny, Sylvia Brost, Ulf Hinz, et al.
Pathology, Research and Practice|December 8, 2014
WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningiomaRonald Koschny, Wolfgang Krupp, Li-Xin Xu, et al.
Cell Death and Differentiation|April 24, 2004
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugsT M Ganten, T L Haas, J Sykora, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2014
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complexRonald Koschny, Christina Boehm, Martin R Sprick, et al.
Pageof 5